Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New revision entry v3.3.2 added and v3.2.0 removed from the Record History page (NCT05446298). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:15:38.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Removed a site-wide notice about funding and NIH operating status from the page. The core trial history content remains unchanged.
    Difference
    0.7%
    Check dated 2025-11-18T07:23:30.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    New history entry dated 2025-07-28 added, updating the study status and oversight details.
    Difference
    0.1%
    Check dated 2025-10-27T20:53:35.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T07:54:16.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.3%
    Check dated 2025-09-29T04:17:55.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no other substantive content changes observed.
    Difference
    0.7%
    Check dated 2025-09-14T21:40:53.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.